Boston Scientific exits global heart valve business
2025-05-29 11:41:04

Reporters learned that Boston Scientific has announced that it will stop selling its transcatheter aortic valve (TAVR) products worldwide because regulators in various countries have stricter requirements for new clinical trial data after the product is launched. Just last month, Boston Scientific's TAVR valve was launched in China.
VR
Email Subscription
Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.
ASIA TECH WIRE

Grasp technology trends

Download